{ "company_number": "09389592", "name": "Newcells Biotech Limited", "url": "/company/09389592", "status": "In Administration", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2015-01-15", "dissolved_on": null, "sic_codes": [ "72110" ], "registered_address": { "id": 207337, "url": "/address/207337", "line1": "11TH FLOOR LANDMARK ST PETER'S SQUARE", "line2": "1 OXFORD STREET", "post_town": "MANCHESTER", "county": "", "country": "", "postcode": "M1 4PB" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09389592", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-10-31", "last_made_up": "2025-01-31", "category": "SMALL", "filings": [ { "url": "/company/09389592/accounts/2025-01-31", "made_up_date": "2025-01-31", "period_start": "2024-02-01", "period_end": "2025-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "44.00", "tangible_fixed_assets": "677246.00", "debtors": "990231.00", "cash_bank_in_hand": "612060.00", "current_assets": "1931781.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "734359.00", "total_assets_less_current_liabilities": "1411605.00", "net_assets_liabilities": "73312.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "74.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-3564336.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2025.zip" }, { "url": "/company/09389592/accounts/2024-01-31", "made_up_date": "2024-01-31", "period_start": "2023-02-01", "period_end": "2024-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "42.00", "tangible_fixed_assets": "430562.00", "debtors": "1713680.00", "cash_bank_in_hand": "2131997.00", "current_assets": "4208562.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3227386.00", "total_assets_less_current_liabilities": "3657948.00", "net_assets_liabilities": "3637648.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "74.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-2491653.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2025.zip" }, { "url": "/company/09389592/accounts/2023-01-31", "made_up_date": "2023-01-31", "period_start": "2022-02-01", "period_end": "2023-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "35.00", "tangible_fixed_assets": "465299.00", "debtors": "1222405.00", "cash_bank_in_hand": "2222434.00", "current_assets": "3871646.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3061512.00", "total_assets_less_current_liabilities": "3526811.00", "net_assets_liabilities": "717689.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "51.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-2522510.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2024.zip" }, { "url": "/company/09389592/accounts/2022-01-31", "made_up_date": "2022-01-31", "period_start": "2021-02-01", "period_end": "2022-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "22.00", "tangible_fixed_assets": "655693.00", "debtors": "869438.00", "cash_bank_in_hand": "1884565.00", "current_assets": "3008601.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2301797.00", "total_assets_less_current_liabilities": "2957490.00", "net_assets_liabilities": "2833111.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "51.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-2092103.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2022.zip" }, { "url": "/company/09389592/accounts/2021-01-31", "made_up_date": "2021-01-31", "period_start": "2020-02-01", "period_end": "2021-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "15.00", "tangible_fixed_assets": "509873.00", "debtors": "559156.00", "cash_bank_in_hand": "5012703.00", "current_assets": "5643627.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4579552.00", "total_assets_less_current_liabilities": "5089425.00", "net_assets_liabilities": "4922214.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "51.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-1132048.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2021.zip" }, { "url": "/company/09389592/accounts/2020-01-31", "made_up_date": "2020-01-31", "period_start": "2019-02-01", "period_end": "2020-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "362911.00", "debtors": "315263.00", "cash_bank_in_hand": "1206326.00", "current_assets": "1600823.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "831701.00", "total_assets_less_current_liabilities": "1194612.00", "net_assets_liabilities": "1090841.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "29.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-605942.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2020.zip" }, { "url": "/company/09389592/accounts/2019-01-31", "made_up_date": "2019-01-31", "period_start": "2018-02-01", "period_end": "2019-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "110378.00", "debtors": "295336.00", "cash_bank_in_hand": "1705161.00", "current_assets": "2049709.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1566405.00", "total_assets_less_current_liabilities": "1676783.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "29.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-249180.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2019.zip" }, { "url": "/company/09389592/accounts/2016-01-31", "made_up_date": "2016-01-31", "period_start": "2016-01-31", "period_end": "2016-01-31", "entity_name": "Newcells Biotech Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1291.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "120628.00", "creditors_due_within_one_year": "9373.00", "creditors_due_after_one_year": "0.00", "net_current_assets_liabilities": "111255.00", "total_assets_less_current_liabilities": "112559.00", "net_assets_liabilities": "112559.00", "called_up_share_capital": "16.00", "profit_loss_account_reserve": "-40934.00", "shareholder_funds": "112559.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2016.zip" } ], "pdf_only_filings": [ { "made_up_date": "2018-01-31", "filing_date": "2018-10-11", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-full", "paper_filed": true, "pdf_url": "/company/09389592/accounts/2018-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09389592/filing-history/MzIxNjU5MTc0NmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2017-01-31", "filing_date": "2017-10-27", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-full", "paper_filed": true, "pdf_url": "/company/09389592/accounts/2017-01-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09389592/filing-history/MzE4ODc2MDk0N2FkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09389592/filing-history" }, "confirmation_statement": { "next_due": "2027-01-29", "last_made_up": "2026-01-15" }, "officers": [ { "name": "DINES, Peter Michael", "person_url": "/person/6852928", "role": "director", "appointed_on": "2022-04-19", "resigned_on": "2024-03-05", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-08-05T11:10:09+00:00" } ], "psc": [ { "name": "Nvm Private Equity Llp", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/OC392261", "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2018-06-20", "ceased_on": "2018-06-20", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Professor Lyle Armstrong", "kind": "individual-person-with-significant-control", "person_url": "/person/2984579", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2018-06-20", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mercia Fund Management Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/06973399", "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2018-06-20", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "North East Accelerator General Partner Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Northstar Ventures Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/05104995", "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }